Performance of qualitative urinary hCG assays

Area of Science:

• Clinical Chemistry
• Point-of-Care Testing
• Immunoassays

Background:

• Qualitative urine human chorionic gonadotropin (hCG) tests are widely used for pregnancy detection.
• Point-of-care testing (POC) assays are common in diagnostic settings, including hospitals.
• Accurate and sensitive hCG detection is crucial for timely and safe medical management.

Purpose of the Study:

• To evaluate the sensitivity and performance of commonly used qualitative urine hCG tests available in Belgium.
• To compare the actual detection limits with manufacturers' claims.
• To assess the implications of test performance in a clinical diagnostic setting.

Main Methods:

• Sensitivity testing of eight different qualitative urine hCG assays.
• Comparison of test results against established hCG concentration standards.
• Survey of Belgian acute care hospitals regarding their use of hCG testing.

Main Results:

• Significant variability in sensitivity was observed among the tested urine hCG assays.
• Only a minority of home-use and professional-use tests met their claimed detection limit of 25 mIU/ml.
• 80% of surveyed hospitals reported using these assays in a diagnostic capacity.

Conclusions:

• The performance of qualitative urine hCG tests is inconsistent, with many failing to achieve claimed sensitivity.
• Suboptimal performance poses risks in hospital settings, potentially leading to inappropriate procedures for early pregnancies.
• Blood-based hCG determination remains the gold standard for accurate pregnancy diagnosis.